文献速递乳腺乳腺X线

筛查乳腺X线摄影中影响假阳性召回的因素

Factors Impacting False Positive Recall in Screening Mammography.
PubMed 文献 · Acad Radiol · 2019-02-14

该研究回顾性分析2015年8月31日至2016年9月30日筛查乳腺X线摄影数据库,共22,055次筛查,召回率8.6%。数字乳腺断层合成(DBT)召回率低于全视野数字乳腺X线摄影(FFDM)(8.0% vs 10.6%,p<0.001),有既往乳腺X线片可比对及有良性乳腺活检史者假阳性召回率更低,假阳性组平均年龄低于真阳性组(56.1 vs 62.9岁,p<0.001)。结论支持在筛查中使用DBT并获取既往乳腺X线片进行对比。

要点

  • DBT召回率8.0%低于FFDM的10.6%(p<0.001)。
  • 有既往乳腺X线片可比对者假阳性率90.8%低于无既往片者95.8%(p=0.02)。
  • 有良性乳腺活检史者假阳性率87.6%低于无该史者92.9%(p=0.01)。

核心结论

  • DBT、年龄较大、有既往乳腺X线片可比对及有良性乳腺活检史与假阳性召回显著降低相关;研究支持在筛查中使用DBT并获取既往乳腺X线片进行对比。

研究设计与样本

  • 回顾性研究,回顾2015年8月31日至2016年9月30日筛查乳腺X线摄影数据库,包括全视野数字乳腺X线摄影(FFDM)和数字乳腺断层合成(DBT),共22,055次筛查乳腺X线摄影。

诊断标准与关键数值

  • 假阳性检查定义为诊断性影像评估为BI-RADS 1或2且随访1年无癌,或诊断性影像评估为BI-RADS 3且随访2年无癌,或活检病理为良性。
  • 真阳性定义为活检或手术切除病理为恶性。
  • DBT召回率8.0% vs FFDM 10.6%,p<0.001。
  • 有既往乳腺X线片者假阳性率90.8% vs 无既往片者95.8%,p=0.02。
  • 有既往良性乳腺活检史者假阳性率87.6% vs 无该史者92.9%,p=0.01。

临床应用与阅片要点

  • 在筛查乳腺X线摄影中可考虑使用DBT以降低召回率。
  • 获取既往乳腺X线片进行对比可能降低假阳性召回。
  • 有良性乳腺活检史的患者假阳性召回率较低。
  • 高龄女性假阳性召回率较低。
  • 高危病变史、乳腺癌或卵巢癌家族史、激素使用、乳腺密度、种族或体重指数与假阳性召回无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Our objective was to identify factors impacting false positive recalls in screening mammography.

MATERIALS AND METHODS: We retrospectively reviewed our screening mammography database from August 31, 2015 to September 30, 2016, including full field digital mammograms (FFDM) and digital breast tomosynthesis (DBT) mammograms. False positive (FP) exams were defined as Breast Imaging-Reporting and Data System (BI-RADS) 1 or 2 assessments at diagnostic imaging with 1 year cancer-free follow-up, Breast Imaging-Reporting and Data System 3 assessment at diagnostic imaging with 2 years cancer free follow-up, or biopsy with benign pathology. True positives were defined as malignant pathology on biopsy or surgical excision. We evaluated the association of FP recalls with multiple patient-level factors and imaging features.

RESULTS: A total of 22,055 screening mammograms were performed, and 1887 patients were recalled (recall rate 8.6%). Recall rate was lower for DBT than full field digital mammograms (8.0% vs 10.6%, p < 0.001). FP results were lower if prior mammograms were available (90.8% vs 95.8%, p = 0.02), and if there was a previous benign breast biopsy (87.6% vs 92.9%, p = 0.01). Mean age for the FP group was lower than the true positive group (56.1 vs 62.9 years, p < 0.001). There were no significant differences in FP recalls based on history of high-risk lesions, family history of breast or ovarian cancer, hormone use, breast density, race, or body mass index.

CONCLUSION: FP recalls were significantly less likely with DBT, in older women, in patients with prior mammograms available for comparison, and in patients with histories of benign breast biopsy. This study supports the importance of using DBT in the screening setting and obtaining prior mammograms for comparison.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Honig EL, Mullen LA, Amir T, et al. Factors Impacting False Positive Recall in Screening Mammography. Acad Radiol. 2019. PMID: 30772138. doi:10.1016/j.acra.2019.01.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。